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Silicon (Si) is the third most abundant trace element in the human body after iron and zinc [1] , 2 although its mean daily intake by adults in the Western world is greater than for these latter 3 two elements and estimated to be 20-50 mg [2] . However, unlike zinc and iron, it is not 4 established whether Si has an essential biological role in humans or other mammals. The 5 highest levels of tissue Si are associated with the mammalian connective tissues, such as bone, 6 blood vessels and skin [3] [4] [5] and Si depletion of the diet was originally reported to result in 7 stunted growth and malformation of the connective tissues [6, 7] . These original findings have 8 not been replicated [8] but more recent studies in humans have reported that Si 9 supplementation, or higher intakes of dietary Si, are associated with an improvement in bone 10 and skin health [9] [10] [11] . Mechanisms of action have not been established, although metabolic 11 and/or structural roles in collagen synthesis and stabilization have been proposed [12] . 12
Si-based treatments and devices have been reported to aid wound healing and prevent 13 scarring [13, 14] . These devices are typically silicone-based and in the form of gels/sheets 14 [15, 16] . They are proposed to act as barriers, maintaining the wound moist (i.e. hydrated) and 15 protecting it against infection. In addition, it has been suggested that Si is released from the 16 dressing, a fact that can be paralleled with existing evidence in humans that organo-silicons 17 can be metabolized to orthosilicic acid [17] . It is proposed that Si reaches the basal epidermal 18 and dermal fibroblast cells, up-regulating the expression of basic fibroblast growth factor (β-19 FGF) [18] . Consistent with these observations, inorganic Si-containing materials, such as 20 bioactive glass ointment and silica gel fiber fleeces [19, 20] , have also been tested for wound 21 healing applications and shown to result in a faster and more efficient cicatrization. 22 Orthosilicic acid (Si(OH)4) is a small molecule that readily diffuses, so maintaining its 23 presence in the wound environment requires some kind of slow release mechanism. In this 24 respect, amorphous silica nanoparticles (NP) may be especially promising candidates for 25 wound healing applications, since not only will they deliver orthosilicic acid up to its solubility 1 limit (circa 2 mM) as they dissolve [21] , but they can also be loaded with additional therapeutic 2 molecules [22] [23] [24] . Although such silica-based drug nanocarriers have been shown to favor 3 cicatrization [25, 26] , native (i.e. non-functionalized) forms have been less studied for their 4 wound healing potential [27] , and, to our knowledge, not at all as 'small' nanoparticles (as 5 opposed to large/aggregated particles) where dissolution to orthosilicic acid is most favorable. 6
In this context, we have herein investigated here the effects of silica in different forms, 7 soluble (i.e. orthosilicic acid) and small nanoparticulate forms (NP, 10 nm in diameter), on the 8 migration and proliferation of human skin fibroblast cells (CCD-25SK), two of the main 9 processes required for cicatrization [28] , with the aim of determining if small (i.e. 10 nm) silica 10
NPs per se can be useful for wound healing applications. 11 12
Materials and methods

13
Synthesis and characterization of the amorphous silica nanoparticles 14
Ludox SM30 was purchased from Sigma-Aldrich Chemical Co (Gillingham, UK). Silica NP 15 (referred to as SiNP+10 or SiNP-10 depending on the sign of their Zeta potential) were 16 synthesized according to the literature [29] . Briefly, tetraethyl orthosilicate (TEOS 98 wt%, 17
Sigma-Aldrich Chemical Co) was added to a stirred solution of L-(+)-lysine monohydrate 18 (Sigma-Aldrich Chemical Co) in ultrapure (UHP) water at 60˚C. After 72 h at this temperature, 19
SiNP-10 negatively-charged particles were obtained. Some of those particles were post-20 functionalized with aminopropyl triethoxysilane as described by Badley et al. [30] . The 21 obtained positively-charged SiNP+10 were then purified by dialysis (Spectra/Por, 25 mm 22 dialysis tubing with pore diameter of 4.2-5.0 nm, from Carl Roth) with 200 mL particle 23 suspensions being dialyzed five times under magnetic stirring against 2 L of ultrapure water 24 (Milli-Q) for a minimum time of 4 h. Silica NPs were also prepared from a concentrated (~ 7 25 M Si) basic (~ pH 14) sodium silicate solution (Sigma-Aldrich Chemical Co). Following 1 dilution to 10 mM in UHP water, the sodium silicate solution was neutralized with 5 M HCl 2 and aged for 24 h before being used [31] . Particles formed with this method are referred to as 3 NaSi10. For comparison, a soluble orthosilicic acid (Si(OH)4) solution was prepared by 4 dilution of the concentrated sodium silicate solution to 2 mM and neutralization with HCl. 5
The different silica NPs were characterized prior to their supplementation in the cell culture 6 medium. Dynamic Light Scattering (DLS) was used to determine the hydrodynamic diameter 7 of the silica NPs in UHP water. The reading (three measurements of at least 10 readings) was 8 carried out at an angle of 175˚ to the incident beam (632.8 nm). Zeta potential was measured 9 on a Malvern Zetasizer (NanoZS) with the particles dispersed in 10 mM KCl. fitting the equation below [21] to the data (eq.1) 17
where C is the apparent Si concentration at time t and Ceq is the apparent Si concentration at 19 equilibrium, as obtained from ICP-OES measurements. 20 21
Cell culture 22
Human skin fibroblasts, CCD-25SK were obtained from ATCC (Manassas, USA) as a frozen 23 aliquot. Cells were resuscitated in complete growth medium [Minimum Essential Medium 24 (MEM), supplemented with 5% foetal calf serum (FCS; Sigma-Aldrich Co., UK), 100 μg mL −1 25 penicillin and streptomycin (Invitrogen Ltd, Life Technologies UK) and 0.25 μg mL −1 1 fungizone (Invitrogen Ltd, Life Technologies UK)] and grown in Nunc T75 culture flasks (75 2 cm 2 ; VWR International, UK) at 37 °C in a humidified atmosphere containing 5% CO2. At 3 approximately 80% confluence, cells were detached from the cell culture flasks with 0.1% 4 trypsin/0.02% EDTA solution, resuspended in complete culture medium (i.e. supplemented 5 MEM medium) and were either passaged or used in the experiments described below. Cells 6 were used between passage 10-20 for the experiments described herein. 7
Silicon supplemented media were prepared fresh by diluting the appropriate amounts of the 8 silica stocks (nanoparticle suspensions or 2 mM soluble orthosilicic acid solution) in complete 9 growth medium to obtain final Si concentrations between 0.01 mM and 0.5 mM Si. 10 11
Cell viability assays 12
Cell viability and proliferation of CCD-25SK cells, following incubation with the Si 13 supplemented media, was quantitatively evaluated with the fluorescent and non-toxic cell dye 14
Resazurin (Invitrogen, Life Technologies UK). Briefly, the Si supplemented media and 15 controls were removed after 24 and 72 h incubation and the cells rinsed with phenol red-free 16 MEM. Cells were then incubated with phenol red-free MEM containing 10% (44 μM) 17
Resazurin for 6 h at 37˚C in a humidified atmosphere containing 5% CO2. Aliquots of the 18 media were then transferred to a flat-bottom 96-well plate and the absorbance measured at 540 19 nm and 595 nm on an optical plate-reader (Labsystems Multiskan RC, Thermo Scientific Inc, 20 USA). To check for false positive results originating from the silica NPs, a control containing 21 just particles was incubated with the Resazurin dye, and this gave negligible absorbance values. 22
23
Cell proliferation assay 24 CCD-25SK cells were seeded in Nunc 48-well plates at an initial cell density of 5,000 cells per 1 well with 1 mL of complete growth medium and left to adhere overnight. The medium was 2 then replaced with the freshly prepared Si-supplemented media. Complete growth medium 3 without Si supplementation acted as the control, whilst complete growth medium supplemented 4 with 50 μM ascorbate-2-phosphate (A-2-P), a promoter of cell proliferation, or 250 nM 5 dexamethasone, a promoter of cell differentiation, were used as positive and negative controls, 6 respectively. Phase-contrast images were acquired every 2 h, over a 24 to 72 h period, with the 7 Essen IncuCyte Zoom live cell imaging system (Essen BioScience Inc., USA). In some 8 experiments cells were exposed to the Si-supplemented media for just 6 h followed by 9 incubation in complete growth medium (i.e. without Si supplementation) for the remaining 66 Thereafter, a wound (scratch) was created in each well using a 'Wound Maker' tool (Essen 20 BioScience Inc). This specialized, high precision tool creates a similar size wound in each well 21 of the plate. The wound was then rinsed thoroughly with complete growth medium to remove 22 the detached cells and fresh Si-supplemented medium or controls were added. Phase-contrast 23 images were then acquired every 2 h, over a 96 h period, with the Essen IncuCyte Zoom live 24 cell imaging system. Phase contrast images were analyzed using the IncuCyte Zoom software, 25 first to determine the initial wound area and then to determine the percentage change (increase) 1 in cell confluence within the wounded area at each time point. Each treatment was assessed in 2 at least two independent experiments, with six replicates per treatment per experiment. 3 4 Statistical analysis. 5
Results are shown as means ± SD, unless otherwise stated. The Shapiro-Wilk Normality Test 6 used to check the data was normally distributed. Differences between control and treatments 7 (silica treatments, A-2-P and dexamethasone) were evaluated by Student t-test. A value of P < 8 0.05 was considered significant. To correct for multiple testing, a Bonferroni correction was 9 applied to the P values (i.e. P/number comparisons). 10 11 12
Results and Discussion
13
Characterization and dissolution behavior of the silica nanoparticles. 14 The different silica NPs were characterized prior to their use in the cellular studies ( Table 1) . 15
All four types of silica NPs investigated (SiNP+10, SiNP-10, Ludox SM30 and NaSi10) had 16 an initial diameter (D) around 10 nm (in UHP water) but DLS studies indicated that SiNP+10 17 and SiNP-10 tended to rapidly form aggregates of 100 nm and 400 nm in diameter, 18 respectively, in the cell culture medium ( Table 1) The dissolution of the different silica NPs in the cell culture medium at 37˚C and 5% CO2 7 was studied by monitoring the concentration of silicic acid by ICP-OES following 8 ultrafiltration of the culture media through 3 kD membrane (Figure 1) . Calculated dissolution 9 rate (dm/dt) was the highest for NaSi10 and the lowest for SiNP+10 whereas Ludox SM30 and 10 SiNP-10 showed similar intermediate values. The presence of the CCD-25SK cells in the 11 culture medium impacted particle dissolution but not in a consistent manner for all particle 12 types ( Table 1) . Overall, after 6 h incubation in the cell culture medium, at 37˚C and 5% CO2, 13 and in the presence of the fibroblast cells, Ludox SM30, SiNP-10 and SiNP+10 remained 14 mostly intact, whereas the NaSi10 particles dissolved readily (90% dissolution). After 72 h, 15 about 70 % of the former particles were solubilized whereas the latter were fully dissolved. The dissolution rate of pure silica NPs under standardized aqueous conditions depends on 7 two main parameters: their specific surface area and the condensation degree of the silica 8 network. Since the particles studied here are non-porous and of similar diameter, the kinetics 9 of soluble silicic acid release can be related to the connectivity of the Si-O-Si network. In this 10 respect, the higher dissolution rate of NaSi10 particles is consistent with the fact that it is 11 prepared from sodium silicate, resulting in a more 'ionic' type network than SiNP10 that are 12 synthesized from silicon alkoxides [33] . Moreover, it has been shown that silica NPs modified 13 with silane moieties (i.e. SiNP+10 particles) dissolve less readily than 'bare' silica NP because 14 their surface is less accessible to water molecules [34] . Furthermore, the positive surface 15 charge of SiNP+10 particles favors the deposition of a protein corona [35] , that may also impact 16 on dissolution kinetics of the particles. All these considerations explain why SiNP+10 particles 17 have the lowest dissolution rate amongst all silica NPs tested. 18
It is interesting to note that the presence of cells did appear to influence silica NP dissolution 1 (Table 1) , albeit not in any apparent consistent direction. Dissolution rate might be decreased 2 due to either adsorption of particles on the cell membrane or internalization of the particles, 3 especially in the case of SiNP+10 whose positive charge was shown to favor their cellular 4 uptake [36] . In contrast, the presence of cells accelerated the dissolution of NaSi10. Since these 5 particles are rapidly converted into a soluble form in the acellular media, it is possible to 6 suggest that, for this system, a 'consumption' of silicic acid, being related to its adsorption or 7 internalization, shifts the equilibrium towards more dissolution. Altogether, these results 8 indicate that the silica NP solutions are dynamic systems where colloidal species coexist with 9 soluble silicic acid and whose behavior and thus cellular effects are directed by key physico-10 chemical parameters, namely size, silica condensation degree and surface charge. 11 12 µM Si, there was no difference between any of the treatments and controls (Figure S1) , 20 consistent with prior findings for soluble silicic acid in different cell types [37, 38] . At 72 h, 21 metabolic activity of the cells was also increased (by ~ 10%) with the positive control, A-2-P, 22 and decreased (by ~ 10%) with the negative control, dexamethasone (Figure 2) . . We doubt whether aggregation of the particles in the medium 13 explains their lack of toxicity, as at least Ludox SM30 and NaSi10 particles remained well-14 dispersed in the cell culture medium ( Table 1) . 15
Effect of silica nanoparticles on viability and proliferation of human dermal fibroblasts 13
Considering cell proliferation, as monitored by live cell imaging, both SiNP-10 and Ludox 16 SM30 induced small (7-18%) but significant increases in confluence above the untreated 17 control after 48 and 72 h incubation (P ≤ 0.03) and were comparable to the positive control A-18 2-P (increase of 15-19%) (Figure 3) . NaSi10 also significantly increased cell growth but at 1 higher concentrations (> 200 µM Si; Figure S2 ). However, the most marked increase in 2 confluence (by 31-59%) was observed with soluble orthosilicic acid. Results were similar for 3 the two Si concentrations (50 and 100 µM) investigated. SiNP+10 had almost no impact on 4 cell proliferation. Dexamethasone, the negative control, decreased the growth of the cultured 5 cells by ~ 70%. 6
The addition of soluble silicic acid up to 30 M Si was previously shown to enhance both 7 the metabolic activity and proliferation of bone cells [44] . A similar effect is observed here 8 that does not vary significantly with Si concentrations of 50 μM or 100 μM. For silica NPs, the 9 cellular effects appear to be strongly dependent on the surface charge and the dissolution 10 behavior of the particles. The negatively-charged particles had only minor effects on the cells: 11 the SiNP-10 and Ludox SM30 particles, that exhibit low rates of dissolution, slightly favored 12 metabolic activity and cell proliferation while NaSi10 particles, despite their higher rate of 13 dissolution, had a significantly lower impact on cell behavior at comparable concentrations. 14 The positively-charged SiNP+10 particles, with a slower dissolution rate, increased metabolic 15 activity similarly to soluble silica and were less efficient in promoting proliferation. This 16 suggests that both colloidal and soluble forms of silica can impact on the cellular behavior but 17 in a different manner. 
Effect of silica nanoparticles on skin fibroblasts in a wound healing model 9
The effects of soluble silicic acid and silica NPs on skin fibroblast cells were investigated in a 10 wound closure model (termed 'scratch assay'). Overall, the silica-treated cells migrated and 11 proliferated to cover the wounded area faster than untreated control cells (Figure 4) . 12 However, not all silica treatments were as effective in promoting wound closure (Figure 4 and  7 Table 2). Soluble silicic acid and SiNP+10 were the most efficient in promoting wound 8 closure. Interestingly the SiNP+10 achieved an apparently greater effect than soluble silicic 9 acid, strengthening the previous assumption that the particles per se had a specific effect on 1 wound closure above being just a source of silicic acid in the medium. 2 3 In order to clarify this point, human skin fibroblasts were exposed to the silica treatments for 8 only 6 h of incubation to limit NP dissolution in the cell culture medium. Again, there was no 9 detrimental effect of the silica NPs on cell growth. Noticeably, SiNP+10 induced the greatest 10 increase in cell proliferation at all the time points investigated (Figure 5) . In contrast, the effect 11 of soluble silicic acid was muted implying that its influence on cell activity requires longer 12 exposure times (e.g. 24-72 h as in Figure 2 ). Therefore silica NPs appear to have two effects in 13 the wound healing model: (1) a rapid, direct stimulatory effect and (2) a delayed effect due to 14 soluble orthosilicic acid being released from the dissolution of silica NP in the culture medium. In parallel, analysis of the incubation medium for total Si, before and after 6 h exposure to 10 cells, showed that for Ludox SM30, NaSi10 and SiNP-10, almost all the added Si was 11 recovered in the medium at 6 h (Figure 6) . In contrast, only 20-25% of the supplemented 12 SiNP+10 was recovered at 6 h and an additional 50-70% was found in the fresh medium at the 1 end of the 76 h incubation period. Therefore these particles appear to be retained, either by 2 adsorption or internalization, by the cells in the first hours of the experiments and then released 3 over time. Fluorescence microscopy imaging of the cells confirmed that SiNP+10 were readily 4 taken up by the fibroblast cells while negatively-charged SiNP-10 appeared to adhere to the 5 cell surface (Figure S3) . Although 3D confocal imaging, which allows full interpretation of 6 events in the Z plane, would be necessary to fully confirm these data, they are consistent with is internalized slowly so that a delay is required before its effect on cell behavior can be 2 observed. In contrast, positively-charged SiNP+10 are rapidly taken-up by the cells, can 3 undergo intracellular dissolution and would thus release silicic acid both inside and outside the 4 cells. Finally, the internalization of negatively-charged particles appears limited, in good 5 agreement with the literature [48] . Hence it is very likely that their positive effect on 6 proliferation and migration is due to the silicic acid released by dissolution in the medium 7 which is taken up by the cells. Indeed our experiments also indicate that adsorption of silicic 8 acid and silica particles on the cell surface can impact on the solubility equilibria and thus on 9 the availability of the different silica forms. Therefore, in the absence of detailed information 10 on the full endocytosis/exocytosis processes associated with silica nanoparticles and on the 11 resulting silica speciation, a precise correlation between the physico-chemical characteristics 12 of the silica NP and their observed biological effects remains difficult. These findings 13 exemplify the complexity of the aqueous chemistry of silica [49] , and especially the co-14 existence of soluble and condensed forms, their relative amounts being highly dependent on 15
[Si], pH, ionic strength and interactions with surrounding ions, molecules or surfaces [22, 47, 16 50-52] . This is one plausible reason for the ongoing lack of understanding of the mechanisms 17 by which silica influences biological processes, despite multiple observations showing that it 18 does happen. 19
20
CONCLUSION 21
Despite all of the work on the toxicity of nanosilica, our results show that ultrafine silica 22 nanoparticles, at appropriate concentrations, can positively impact the proliferation and 23 migration of CCD-25SK human skin fibroblast cells in a way that is anticipated to promote 24 wound healing. Whilst supporting the previous assumption that silicic acid is the bioactive 25 form of silica, our findings also suggest that this form is not readily internalized by the cells. 1 However, provided that they exhibit a positively-charged surface a rapid cellular uptake of 2 small silica NP can occur. We propose that they thus act as a bolus delivery form of bioactive 3 silicic acid that becomes available upon intracellular dissolution. Hence, in parallel with a 4 continued effort to analyze the influence of soluble silica on cell metabolism, further 5 understanding of the intracellular fate of silica NPs is necessary. At the same time, these results 6 open new perspectives for the application of silica nanoparticles as topical therapy where the 7 intrinsic bioactivity of silicic acid may be combined with that of a loaded drug. 8 9 10 11
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